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The genus Yersinia has been used as a model system to study path-
ogen evolution. Using whole-genome sequencing of all Yersinia spe-
cies, we delineate the gene complement of the whole genus and
define patterns of virulence evolution. Multiple distinct ecological
specializations appear to have split pathogenic strains from environ-
mental, nonpathogenic lineages. This split demonstrates that con-
trary to hypotheses that all pathogenic Yersinia species share
a recent common pathogenic ancestor, they have evolved indepen-
dently but followed parallel evolutionary paths in acquiring the
same virulence determinants as well as becoming progressively
more limited metabolically. Shared virulence determinants are lim-
ited to the virulence plasmid pYV and the attachment invasion locus
ail. These acquisitions, together with genomic variations in meta-
bolic pathways, have resulted in the parallel emergence of related
pathogens displaying an increasingly specialized lifestyle with a
spectrum of virulence potential, an emerging theme in the evolution
of other important human pathogens.
genomics metabolic streamlining | pathoadaptation | Enterobacteriaceae
Bacterial species are defined on the basis of phenotypic char-acteristics, such as cellular morphology and biochemical char-
acteristics, as well as DNA-DNA hybridization and 16S rRNA
comparison. Using high-throughput whole-genome approaches we
can now move beyond classic methods and develop population
frameworks to reconstruct accurate inter- and intraspecies rela-
tionships and gain insights into the complex patterns of gene flux
that define different taxonomic groups.
Bacterial whole-genome sequencing has revealed enormous
heterogeneity in gene content, even between members of the
same species. From a bacterial perspective the acquisition of new
genes provides the flexibility to adapt and exploit novel niches
and opportunities. From a human perspective, integration of
genes by bacteria has been directly linked to the emergence of
new pathogenic clones, often from formerly harmless lineages (1,
2). In addition to gene gain, gene loss is also strongly associated
with host restriction in acutely pathogenic bacterial species, such
as Yersinia pestis and Salmonella enterica serovars, including Sal-
monella Typhi (3–5), where gene loss can remove functions un-
necessary in the new niche (6). These specialist pathogens show
a much higher frequency of functional gene loss than closely
related host generalist pathogens, such as Yersinia pseudotuber-
culosis (7).
Previous Yersinia genome studies (8, 9) have examined the
evolution of pathogenicity by comparing strains from a selection
of species or species subtypes within the genus, limiting our
understanding of the evolutionary context of individual species.
The majority of the Yersinia species are found in the environ-
ment and do not cause disease in mammals. Three species are
known as human pathogens: the plague bacillus Y. pestis and the
enteropathogens Yersinia enterocolitica and Y. pseudotuberculosis.
Significance
Our past understanding of pathogen evolution has been frag-
mented because of tendencies to study human clinical isolates. To
understand the evolutionary trends of pathogenic bacteria
though, we need the context of their nonpathogenic relatives.
Our unique and detailed dataset allows description of the parallel
evolution of two key human pathogens: the causative agents of
plague and Yersinia diarrhea. The analysis reveals an emerging
pattern where few virulence-related functions are found in all
pathogenic lineages, representing key “foothold” moments that
mark the emergence of these pathogens. Functional gene loss
and metabolic streamlining are equally complementing the evo-
lution of Yersinia across the pathogenic spectrum.
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Only Y. pestis and Y. pseudotuberculosis have been studied ex-
tensively in a phylogenetic context (7, 9, 10). In our study, we
present a global analysis of diversity in multiple isolates repre-
senting all current species of the Yersinia genus to examine the
evolution of bacterial pathogens in the context of the entire
genus, encompassing both genomic features and metabolic sig-
natures. It has been previously suggested that the pathogenic
Y. pestis, Y. pseudotuberculosis, and Y. enterocolitica share a recent
common ancestor to the exclusion of the nonpathogenic species
(11–13). Contrary to this, we show conclusively that the human
pathogenic Yersinia lineages have evolved independently. Early
ecological separation is likely to have split the most acutely
pathogenic Yersinia strains from the environmental species and
nonpathogenic Y. enterocolitica. In human pathogenic lineages
this was then followed by a common pattern of acquisition of
similar pathogenicity determinants, namely the virulence plasmid
pYV and the invasin ail, followed by the acquisition of further
determinants within lineages along with functional gene loss and
reduced metabolic flexibility. This parallel evolution in distinct
pathogenic Yersinia species may represent a paradigm of the
emergence of important human pathogens from nonpathogenic
bacterial species.
Results
Defining the Structure of the Genus Yersinia. To investigate the
evolution of pathogenicity within the genus Yersinia we selected
a representative sample of strains composed of Y. pseudotuber-
culosis and Y. pestis, as well as the understudied Y. enterocolitica.
In addition, a diverse set of 94 isolates representing all of the
other 15 Yersinia species were also sequenced. In total, 241
Yersinia strains were analyzed, all of which had been typed by
traditional biochemical and serological methods (Table S1).
Because high diversity within the population precluded the use
of a read mapping-based approach, we used a set of core genes
common to all strains to produce a genus-wide phylogeny. The
resulting phylogenetic tree (Fig. 1 and Fig. S1) shows a wide
diversity of clearly defined lineages within the genus, with clus-
tering of isolates at the tips of long branches signifying very an-
cient common ancestry. To subdivide the population by patterns
of shared sequence similarity we used the program Bayesian
Analysis of Population Structure (BAPS) (14). BAPS resolved the
genus into 14 species clusters (SC) (Fig. 1). Routine Yersinia
species identification is largely based on limited biochemical data.
Superimposing this information onto the phylogenetic tree
revealed the lack of resolution provided by biochemical tests,
and emphasized the need to use modern molecular methods in
classifying bacterial species. Yersinia frederiksenii is known to be
heterogeneous and Yersinia massiliensis was recently subspeciated
from “atypical” Y. frederiksenii (15). As can be seen in Fig. 1,
isolates described traditionally as Y. frederiksenii can be found in
species complexes SC8, SC9, and SC14, with the latter also
containing both Yersinia intermedia and Y. massiliensis isolates.
On the other hand, the three species Yersinia aleksiciae, Yersinia
bercovieri, and Yersinia mollaretii form a single, heterogeneous
species complex SC13 (Fig. 1). In line with previous findings, the
pathogenic lineages of Y. pestis and Y. pseudotuberculosis form a
tight group (16), with the nonpathogenic Yersinia similis appear-
ing basal to these species on the tree (17) (Fig. 1). The other
human pathogenic species, Y. enterocolitica, forms a pair of dis-
tinct complexes in the tree, SC6 composed of the pathogenic
biotype (BT) 1B and the nonpathogenic BT 1A, and SC7 com-
posed of the other pathogenic BTs 2–5 (Fig. 1).
The remaining species occupy intermediate branching posi-
tions between the Y. pseudotuberculosis and Y. enterocolitica SCs
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Fig. 1. The phylogeny of the genus Yersinia and the virulence plasmid pYV. Maximum-likelihood phylogenetic tree of the genus Yersinia based on the
concatenated sequence of 84 housekeeping genes. Current species assignments based on biochemical typing (36) (color circle borders) are contrasted with the
species complexes (colored circles) as allocated by BAPS. The SC for the Y. frederiksenii type strain (8) is depicted by an asterisk. Arrows show the independent
acquisition events of the virulence plasmid pYV. The pYV plasmid tree for pathogenic Y. enterocolitica and Y. pseudotuberculosis samples is shown.
2 of 6 | www.pnas.org/cgi/doi/10.1073/pnas.1317161111 Reuter et al.
with the fish pathogen, Yersinia ruckeri, falling on a distinct di-
vergent branch (SC2) (Fig. 1). This branch is also occupied by
Yersinia entomophaga and Yersinia nurmii, two newly character-
ized species grouped within a single species cluster, SC3.
Plotting the Distribution of Known Virulence Functions Across the
Genus. Numerous studies have defined important virulence
determinants in Y. pseudotuberculosis/pestis and Y. enterocolitica
(18–23). Analysis of these virulence genes has formed a central
narrative in our understanding of the evolution of these pathogens.
However, athough these determinants have been well characterized
in human pathogenic lineages, their origin and distribution across
other members of the genus remain unclear or incomplete.
From the phylogenetic distribution of known pathogenicity
determinants (Fig. 2 and Dataset S1) it is evident that the dis-
tribution of virulence-related genes falls into three broad cate-
gories: (group I) genes represented in all lineages of the genus,
(group II) genes selectively gained or lost, wholly or partially, by
entire lineages, and (group III) those peculiar to single isolates.
Virulence-related genes present in all lineages (group I) in-
clude the Flag-1 flagella biosynthesis cluster and the global vir-
ulence regulator RovA (Fig. 2), which controls the expression of
multiple key virulence factors (23, 24). RovA has been suggested
as a promiscuous ancestral regulon into which related as well as
unique functions were incorporated multiple times in different
lineages, as indicated by the little overlap of regulatory networks
between Y. enterocolitica and Y. pseudotuberculosis (23).
Selectively acquired or lost genes in group II include a chro-
mosomal type 3 secretion system (T3SS) recently described in
Y. enterocolitica (25–27). This system is most similar to the an-
cestral Salmonella pathogenicity island 2 (SPI-2) encoded T3SS
and we propose to call it Yersinia genus T3SS (Ygt). T3SS have
been associated with important roles in bacterial disease be-
cause they allow direct injection of T3SS effector proteins into
eukaryotic cells. Although there is clear evidence for the pres-
ence of Ygt in all Yersinia lineages, it appears to be in the process
of being lost in the highly pathogenic species (Fig. 2). It is also
clear that the loss of Ygt is always coincident with the acquisition
of an alternative T3SS: either chromosomal Ysa or the virulence
plasmid, pYV, bearing the Yop T3SS (see below).
Group II also includes metabolic pathways including the co-
balamin (vitamin B12) biosynthetic operon (cob), 1,2-propanediol
utilization pathway (pdu), tetrathionate respiration genes (ttr),
hydrogenase complexes (hyd4 and hyd2), and cellulose bio-
synthesis pathway (cel). Across the genus, these dispersed oper-
ons are absent from a distinct branch of the Yersinia phylogenetic
tree encompassing SC1–3 (Y. pestis, Y. pseudotuberculosis, Y. similis,
Y. ruckeri, Y. nurmii, and Y. entomophaga), except for ttr, which has
been independently deleted in SC1 and -2, and is only maintained
by SC3 (Figs. 1 and 2). The distinct distribution of these functions
across the genus is likely to be evidence of early ecological spe-
cialization in Yersinia lineages. Salmonella, like Yersinia, synthesizes
cobalamin only under anaerobiosis (28, 29) and is able to degrade
1,2-propanediol or ethanolamine by cobalamin-dependent enzymes
using tetrathionate as a terminal electron acceptor, making the
endogenous production of cobalamine essential for growth (30).
Tetrathionate was previously thought to be important for environ-
mental survival, but has now been shown to be produced in the
vertebrate inflamed gut following the host’s response to Salmonella
Typhimurium infection, whereby the SPI-1 and -2 encoded T3SS
are essential for stimulating the inflammatory response (31, 32).
This widely distributed metabolic capability of Yersinia SCs 4–14
could provide a competitive growth advantage similar to that
observed in S. Typhimurium over the largely fermentative gut
microbiota by using naturally occurring carbon sources that are
not readily fermented.
Only two acquisitions were evident on the tree as delimiters
between pathogenic lineages and their most closely related
“environmental” or nonpathogenic sister taxa (Fig. 2, group III,
and Dataset S1). These “foothold moments” are the acquisition
of the chromosomal attachment and invasion locus ail (19) (Fig.
2) and the plasmid pYV. Plasmid pYV encodes the Ysc-Yop T3SS
apparatus, Yop-secreted protein effectors and chaperones (33),
and is required for optimal virulence in all human pathogenic
Yersinia. Reconstructing the phylogenies of pYV (Fig. 1) showed
far fewer mutation events than would be predicted from the ge-
nus tree, but that it segregated with the host lineages. Also, unlike
any other pYV lineage, pYV from BT 1B strains (SC6) possess
a distinct origin of replication (34, 35). The most parsimonious
explanation for the isolated presence of highly similar plasmids at
extremes of the core phylogenetic tree is that recent independent
acquisition of distinct versions of pYV has occurred in both the
Y. enterocolitica lineages SC6 and -7, as well as the Y. pseudotuber-
culosis/pestis lineage SC1, contrary to existing hypotheses (11–13).
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Fig. 2. Distribution of pathogenicity determinants
across the genus. Three broad groups of pathoge-
nicity determinants present in the genus are high-
lighted (see text and Dataset S1). Heatmap colors are
based upon average amino acid identity either of
single genes or as an average of the amino acid
identity across the genes in the operon, as indicated.
The percent identities were identified using BLAST
searches of the assembled genomes. The corre-
sponding species complexes (Fig. 1) and PGs (Fig. 3)
are highlighted. Comparator sequences used: 1, Y.
enterocolitica (YE8081); 2, Y. enterocolitica (YE212/
02); 3, Y. pseudotuberculosis (IP32953); 4, Y. pestis
(CO92); 5, Y. intermedia (ATCC29909). Gene names
are given for pathogencity determinants, operons are
labeled with their names. Abbreviations: Flg, flagella
cluster; Ygt, Yersinia genus T3SS; 2-CS, two com-
ponent system; eff, effectors; reg, regulator; app,
apparatus; mem, membrane proteins; met (salv),
methionine (salvage); YAPI, Yersinia adhesion patho-
genicity island; T2SS, type 2 secretion system (general
secretion pathway); fes/fep, siderophore operon;
tcPAI, toxin complex pathogenicity island; HPI, high-
pathogenicity island.
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Evolution of Pathogenic Lineages Within Y. enterocolitica. Tradi-
tionally the Y. enterocolitica species cluster has been divided into
six biotypes BT 1A, BT 1B, and BT 2–5 (36), which are further
subdivided into various serotypes (Fig. 3 and Table S1). Biotyping
is based on a number of biochemical tests that assesses the
metabolization or acid production of a panel of metabolites (Fig.
3). The biotypes show differing pathogenic potential in the mouse
model, with BTs 1A, BT 1B, and BTs 2–5 being described as non-,
high-, and low-pathogenic lineages, respectively (11). Examining
the phylogenetic relationships of the species using SNPs called
against the reference BT 1B strain 8081 (37) revealed six distinct
lineages (Fig. 3). BT 1A and 1B form discrete clusters, whereas
BTs 2–5 consist of four closely related but distinct lineages,
confirmed by BAPS clustering (Fig. 3). For the low-pathogenic
Y. enterocolitica lineages, the phylogeny is largely congruent with
serotype (Fig. 3). In subsequent analyses the six Y. enterocolitica
lineages will be referred to as phylogroups (PG) 1–6.
The extent of divergence within the Y. enterocolitica SC is
striking. PGs 3–6 display tight clusters with short terminal branches
compared with PGs 1 and 2. One possible explanation for the low
genetic diversity within PGs 3–6 is that they are the product of one
or more recent population bottlenecks or population expansions.
Although there is no discernible clustering of PGs 3–6 according to
host origin, the strong correlation between the phylogenetic signal
and serotype in this group may suggest that their early evolution
was dominated by ecological specialization.
The Evolution of Y. enterocolitica Is Marked by a Reduction in
Metabolic Capacity and Functional Gene Loss. It is evident from
the results of the 12 classic biotyping reactions (Fig. 3) that
metabolic flexibility differs between the diverse PGs 1 and 2
and the nondiverse PGs 3–6. This difference in metabolic flexibility
does not appear to result from markedly different distributions of
the functional genes possessed by each phylogroup represen-
tative (Fig. S2A), but it does correlate with the accumulation of
pseudogenes and the expansion of insertion sequence elements
(Fig. S2B and Table S2). The absolute numbers of pseudogenes
varies significantly (χ2 test P value 5.5E-59) between the dif-
ferent Y. enterocolitica lineages with the highest number present in
strains in PGs 3 and 6 and the lowest in PG 1 strains. However,
there is no significant difference in the class distribution between
phylogroups, suggesting a general loss of functions across all
classes (Fig. S2B). In agreement with the observed link between
genetic and metabolic decay, PG 6 strains, with their high
numbers of pseudogenes, have not been isolated from livestock
and are reported to be host restricted to hares (38, 39).
To determine whether the signal seen from biotyping extended
to the whole metabolic capacity of the biotypes, we selected
representative strains from each of the six Y. enterocolitica phy-
logroups and tested their ability to metabolize a wide range of
different carbon, nitrogen, sulfur, and phosphate sources on a
phenotypic microarray (Biolog). The resulting signal values
correspond to the intensity of utilization for different nutrient
sources (Fig. S3 and Dataset S2). Variability in metabolic
flexibility is evident across the 380 metabolic tests, with PG 1
strains showing the broadest metabolic capacity and the PG 6
strains exhibiting the most extreme loss of capacity. Principal
component analysis (Fig. S4) using the phenotypic signals showed
a clear separation between PGs 1, 2–5, and 6 along the first
component, accounting for ∼60% of the variance in our pheno-
typic data matrix. We interpret this component as capturing
a gradient of metabolic restriction, from the broadly active en-
vironmental PG 1 strains to the host-restricted PG 6 strain. We
believe that the lack of a specific metabolic signal together with
the observation that most of the mutations in the PGs 3–6 are
derived from single insertion/deletion events suggests that the
genome decay seen in PGs 3–6 is the result of recent evolutionary
events. This finding is also consistent with the short evolutionary
distance observed in the branch leading to PGs 3–6 (Fig. 3).
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Fig. 3. The phylogeny of Y. enterocolitica. Maxi-
mum-likelihood phylogeny for the species based on
SNPs across the whole genome excluding laterally
acquired elements and phages. Lineages are char-
acterized by biotype, biological origin, country of
origin, and serotype. The biochemical tests used for
biotyping (36) of Y. enterocolitica are presented for
each strain. Shaded boxes highlight results of geno-
mic serotype analysis differing from in vitro results.
Biotyping reactions are: 1, salicin acid production; 2,
pyrazinamidase activity; 3, esculin hydrolysis; 4, lipase
activity; 5, indole production; 6, xylose acid pro-
duction; 7, trehalose acid production; 8, sorbose acid
production; 9, nitrate reduction; 10, ornithine decar-
boxylase; 11, Voges-Proskauer test; 12, inositol acid
production.
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Like the phylogenetic analyses, the phenotypic results em-
phasize the parallelism between the two pathogenic species
clusters. It has been shown that combined plasmid gain and
chromosomal gene loss was a predominant driving mechanism in
the evolution of the highly specialized, lifestyle-restricted clone
Y. pestis, which lacks the metabolic repertoire of the wider
Y. pseudotuberculosis species cluster. The reduction of meta-
bolic flexibility through gene loss from the ubiquitous plasmid-
negative PG 1 strains to the lifestyle-restricted PG 6 is particularly
striking, and appears to show a similar pattern to that observed in
the gradient from Y. similis to Y. pseudotuberculosis and Y. pestis.
This appears to be a case of parallel evolution of virulence within
a bacterial genus.
Discussion
The data presented here bring together our often fragmented
view of bacterial pathogen evolution. Through whole-genome se-
quencing of over 200 genomes we have provided a robust frame-
work to redefine the species clusters of this genus, mapping genetic
traits across its full diversity and scoring the significance of path-
ogenicity genes based on their presence or absence. By looking at
functions gained and lost from specific lineages it is clear that there
are metabolic functions, such as the ability to make endogenous
vitamin B12 or anaerobically respire tetrathionate that differentiate
SC1 and -2 from all other Yersinia lineages (Fig. 1). The wide
phylogenetic distribution of these functions suggests they are an-
cestral, important for growth in a range of niches, and have been
lost rather than gained in specific lineages.
It has been previously subject to debate whether human path-
ogenic Yersinia shared a common pathogenic ancestor (11–13). In
fact, the pathogenic lineages occupy positions at diametrically
opposite ends of the Yersinia genus tree. From studies looking at Y.
enterocolitica pathophysiology we know that infections are char-
acterized by inflammation of the gut and sometimes of the mes-
enteric lymph nodes. It is also clear that inflammation requires
pYV, as without it there is no inflammation and pYV-cured
Y. enterocolitica are rapidly eliminated from the gut (40). In
Y. pestis, pYV has been shown to have an early anti-inflammatory
effect preceding the inflammatory response of the host. Although
not demonstrated in Y. enterocolitica, it may be speculated that
a similar early anti-inflammatory effect is necessary for Y. enter-
ocolitica to establish itself at the site of infection before the onset
of the host inflammatory response (41), Either way, it is clear that
pYV is a key factor allowing Y. enterocolitica to persist in the
mammalian gut lumen long enough for the host to mount an
inflammatory response. In the course of such an inflammatory
response tetrathionate is produced, and can be used to gain
a metabolic advantage over the resident gut microbiota (32). This
finding may partly explain why the acquisition of pYV repre-
sented an apparent foothold moment in the evolution of these
pathogens, allowing them to exploit a new niche.
The dispensability of metabolic functions in Y. pestis can be
explained by adoption of a lifestyle bypassing the gut infection
phase, and for Y. pseudotuberculosis similar losses are likely to be
explained by its greater invasiveness and occupation of alterna-
tive niches away from the mammalian gut. Because even the
nonpathogenic members of SC 1–3, such as Y. similis, have lost
these functions, this is evidence of an early change in niche be-
fore the evolution of the other human pathogenic Yersinia spe-
cies in SC1. This finding may also explain why the evolution of
pathogens in SC 1 is markedly different from Y. enterocolitica SC
6–7 in terms of gene gain. Y. pestis is characterized by the ac-
quisition of an array of mostly plasmid borne virulence functions,
which apart from pYV are found nowhere else in the genus.
Despite the differences in metabolic pathways there is con-
siderable symmetry between the two branches leading to the
pathogenic Yersinia; both have closely related nonpathogenic
relatives and have independently acquired pYV. In addition,
species clusters within these lineages show signs of having passed
through an evolutionary bottleneck. Although this process has
been well described for Y. pestis, it is evident from these data that
much of the diversity has been similarly removed in Y. enter-
ocolitica PG 3–6 populations. Large-scale functional gene loss
through pseudogene formation and insertion sequence element
expansion is evident in both lineages generally, but especially in
the most extreme host-restricted PG 6 strains and Y. pestis (3).
Looking outside of the Yersiniae, these signatures have also been
shown to occur in recently emerged pathogens, such as S. Typhi
(4), where they too are considered to be indicative of a recent
evolutionary bottleneck and a change in lifestyle or niche (42).
The patterns of niche adaptation and metabolic streamlining
seen in PG 3–6 strains, unlike Y. pestis, are likely to be the
consequence of transition from environmental ubiquity to spe-
cialization in enteric infection of animals rather than adapting to
a new lifestyle including an insect vector.
What is significant about Yersinia is that until now we have
associated widespread functional gene loss with acutely patho-
genic lineages. Although this is true of Y. pestis, it is not com-
pletely true for Y. enterocolitica, where the degraded genomes
are found in PG 3–6 strains. These latter strains show limited
pathogenicity in mouse models and, although not the most acute
pathogens, are the most successful lineages in terms of disease
causation. These series of events that appear as common evo-
lutionary paths in the most distant Yersinia lineages, and across
the Enterobacteriaceae, are markers of the emergence of lineages
with an increasingly restricted lifestyle. These highly adapted
organisms can cause a spectrum of disease and have emerged
independently, on multiple occasions, out of an environmental
background to become successful human and animal pathogens.
Thus, these dramatic genetic changes we have demonstrated in
the genus Yersinia form a paradigm rather than a unique com-
bination of chance events, and appear to underlie the emergence
of pathogenic enterobacteria.
Materials and Methods
Sequencing and Assembly. The genomes of six Y. enterocolitica strains (YE12/
03, YE56/03, YE53/03, YE212/02, YE149/02, YE3094/96) were sequenced and
completed to an Improved High Quality Draft (43) standard using multiple
sequencing technologies (ABI3730 automated sequencers 2× coverage,
454/Roche GS20/FLX 30× coverage, and Illumina GAII 60× coverage). End-
sequenced PCR products were used to close gaps and scaffold large repeat
regions. The assembly was corrected using ICORN (44).
Sequence for the worldwide collection was generated to a minimum of
20-fold coverage using the Illumina sequencing platform (GAII instruments;
6–12 samples per lane of sequencing, 200- to 300-bp fragments, 76-bp paired-
end reads). This collection included 27 Y. pseudotuberculosis and 118
Y. enterocolitica strains, as well as further 78 isolates of environmental
species, plus previously published genomes (Table S1). The genome ac-
cession numbers can be found in Table S1.
Phylogenetic Analysis. To determine the phylogenetic relationship of the
genus Yersinia housekeeping genes present, all Yersinia sequenced were
identified based on maximum of 25% SNP divergence between Y. pestis
and Y. enterocolitica. The genes were extracted from de novo velvet
assemblies (45) and a concatenated sequence of the chosen 84 genes
encompassing 99,724 bases (Table S3) was used to reconstruct the phy-
logeny of the chromosome. The plasmid alignment was generated by
mapping sequenced reads against pYVe8081 (46). See Dataset S3 for
single copy core genes used for reconstruction of pangenome genus
phylogeny of 50 representative isolates (Fig. S1).
The concatenated sequences for the chromosome and pYV plasmid were
both used to construct an unrooted phylogeny using RAxML with a general
time-reversible evolutionary model and γ-correction for among site rate
variation. Species complexes were defined using the BAPS program (14) run
for three independent iterations with upper population sizes of 25, 30, and
35, to obtain the optimal clustering of the population (47).
The Y. enterocolitica SNP analysis was based on whole-genome alignment
produced by mapping using the YE8081 genome as reference as described
previously (46). Mobile genetic elements were removed, and the resulting
SNP alignment was analyzed using RAxML (see above). Hierarchical BAPS
clustering was performed to define the population structure.
Search for Genes and Operons Related to Virulence and Pathogenicity. Viru-
lence genes were identified using BLAST searches of the assembled genomes
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(Dataset S1). Heatmap colors are based upon average amino acid identity
either of a gene, where a single gene is examined, or as average of the
amino acid identity across the genes in the operon, as indicated.
Phenotypic Microarray Experiment and Analysis. Bacterial strains were cultured
on Luria Bertani agar plates at 25 °C. Inoculation and preparation was as
manufacturer instructions (Biolog). PM1, 2A (both carbon), PM3B (nitrogen),
and PM4A (phosphorus, sulfur) were chosen. L-Cystine (homo-dimer of L-cys-
teine, 12.5 μM) was added as a reduced sulfur source to all plates, and sodium
pyruvate (2M) was added to PM3B and 4A. Plates were incubated under
aerobic conditions for 48 h at 28 °C in the OmniLog Incubator/Reader, taking
readings every 15 min. Three biological replicates were conducted for each
experiment. Data were exported and analyzed in R with datapoints being
transformed in to signal values, as described previously (Dataset S2) (48). Each
plate showed a clear bimodal distribution of signal values, and normal dis-
tributions were fitted to the two peaks to characterize metabolic activity
(“off” and “on”). Log-odds scores were calculated for each data point showing
how likely the “on” distribution was for each nutrient source. A conservative
cut-off of four times more likely to be “on” than “off” was used for further
analysis. The limma R/Bioconductor package was used to examine differential
metabolism whereby all strains were compared with YE8081c, and the Ben-
jamini-Hochberg corrected P values were used to determine statistical signif-
icance of differences controlling for a false-discovery rate of 10%.
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